Skip to main content

Table 1 Basic characteristics of study population.

From: Clinical and biological role of secretory phospholipase A2 in acute respiratory distress syndrome infants

 

ARDS group (n= 24)

Control group (n= 14)

P

Age (months)

4 (2-10.5)

6.5 (2-10.5)

0.457

Weight (Kg)

5.5 (4-10.8)

7 (4.8-9.6)

0.796

Male sex

13 (54.2)

8 (57.1)

0.643

PRISM-III24

16.5 (8.5-20.5)

3 (2-5.5)

<0.001

Modified Murray's score

5 (4.2-6)

0.75 (0.5-1.1)

<0.001

PaO2/FiO2

127 (86-158)

510 (358-667)

<0.001

OI

12.7 (9.9-18.5)

1.7 (1.2-2.2)

<0.001

Crs (mL/cmH2O/kg)

0.35 (0.24-0.4)

0.9 (0.8-0.9)

<0.001

Deaths

3 (12.5)

1 (7.1)

0.627

Co-morbidities

Severe sepsis (5)

Metabolic disease (1)

 
 

RSV infection (4)

SAH (1)

 
 

H1N1 flu (4)

Status epilepticus (2)

 
 

Aspiration (3)

General anesthesia (10)

 
 

Smoke inhalation (4)

  
 

Trauma (2)

  
 

Late onset GBS infection (1)

  
 

Malignancy (1)

  
  1. Data are expressed as median (interquartile range) or number (%). Murray's score, PaO2/FiO2, OI and Crs are measured or calculated just before the bronchoalveolar lavage. Co-morbidities indicate the ARDS etiology or the reasons for intubation in controls.
  2. ARDS: acute respiratory distress syndrome; Crs: respiratory system static compliance; GBS: Group B streptococcus; HFOV: high frequency oscillatory ventilation; OI: oxygenation index; RSV: respiratory sincitial virus; SAH: sub-arachnoid hemorrhage.
Back to article page

Critical Care

ISSN: 1364-8535